Delivery Order SPE2DX15D8002-SPE2DX24F2TH4

Award Date 10/17/23

Potential Completion Date 10/18/23

Potential Value $1.2K

Federal Agency

Medical Supply Chain

Awardee

Dakota Drug, Inc. H544BCGUKW64

Ultimate Awardee

Not listed

NAICS Category

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Minot, ND, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2TH4, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to the prime contractor Dakota Drug, Inc. The contract is for the delivery of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,245.99 and a completion date of October 18, 2023. Dakota Drug, Inc. is a self-certified small disadvantaged business registered in the System for Award Management (SAM.gov) and operates as a for-profit Subchapter S corporation. The company has a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00, which allows it to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to the Defense Logistics Agency's medical supply chain.

Generated 5/12/25, 10:49 AM